Key Takeaways
- • Nest, the UK's largest pension scheme by member count (£55bn AUM, 11.1 million members), committed a further £500m to Schroders Capital's private equity mandate, bringing total committed capital to that strategy to £1.5bn, with focus on AI, healthcare, pharmaceuticals, and technology across North America, Asia, and Europe.
- • Nest appointed Crescent Capital Group to manage a $858.5 million (£450m) direct lending mandate targeting secured, first-priority loans to US middle-market private companies in non-cyclical sectors including healthcare, technology, consumer, and industrial.
- • Nest is executing an ambitious private markets expansion strategy targeting 30% allocation to private assets by 2030, up from approximately 15% currently, significantly exceeding the Mansion House Accord's 10% benchmark and the Accord's 5% UK private asset target.
- • Nest holds approximately £2bn in direct unlisted equity investments across its portfolio, with £381m (18%) allocated to UK companies, demonstrating material capital deployment into domestic private markets through both Schroders and IFM Investors partnerships.
- • The pension scheme's structural advantage—cash flow positive status with a young member base and long investment horizon—enables it to access illiquidity premiums and deploy capital into higher-returning private market strategies unavailable to many institutional investors.
Summary
Nest, the UK's largest master trust pension scheme with £55bn in assets under management and 11.1 million members, is intensifying its private markets allocation strategy through multiple major commitments announced in October 2025. The scheme has increased its investment into Schroders Capital's private equity mandate by £500m, bringing cumulative commitments to that partnership to £1.5bn. Schroders Capital's mandate targets both established and growth-stage businesses at the forefront of innovation, with particular focus on artificial intelligence, healthcare, pharmaceuticals, and technology sectors across North America, Asia, and Europe, including the UK.
Concurrently, Nest selected Crescent Capital Group to manage a $858.5 million (£450m) direct lending mandate focused on secured, first-priority loans to US middle-market private companies. The capital will be deployed across non-cyclical sectors including healthcare, technology, consumer goods, and industrial businesses, with preference for companies generating strong recurring revenues and high free cash flows. According to Rachel Farrell, director of public and private markets at Nest Invest, these investments reflect the scheme's priority of "delivering positive, long-term outcomes for our members" while broadening exposure to global credit markets through managers with differentiated expertise and strong track records across market cycles.
These commitments are integral to Nest's broader strategic objective to expand private market allocation to 30% of total assets under management by 2030, a target that substantially exceeds both the Mansion House Compact benchmark of 10% and the Accord's 5% UK private asset target. Currently, private markets represent approximately 15% of Nest's portfolio. The scheme already maintains approximately £2bn in direct unlisted equity investments, with £381m (18%) deployed into UK companies, demonstrating material capital already flowing into domestic private assets. Nest's structural positioning—its young member base and decades-long cash flow positive status—provides significant competitive advantage in accessing illiquidity premiums and pursuing longer-term private market strategies. The scheme's partnership strategy centers on working with a "tight group of managers in large-scale partnerships," including recent equity co-ownership of IFM Investors, positioning it as a leading institutional capital provider in European, UK, and US private markets.
Concurrently, Nest selected Crescent Capital Group to manage a $858.5 million (£450m) direct lending mandate focused on secured, first-priority loans to US middle-market private companies. The capital will be deployed across non-cyclical sectors including healthcare, technology, consumer goods, and industrial businesses, with preference for companies generating strong recurring revenues and high free cash flows. According to Rachel Farrell, director of public and private markets at Nest Invest, these investments reflect the scheme's priority of "delivering positive, long-term outcomes for our members" while broadening exposure to global credit markets through managers with differentiated expertise and strong track records across market cycles.
These commitments are integral to Nest's broader strategic objective to expand private market allocation to 30% of total assets under management by 2030, a target that substantially exceeds both the Mansion House Compact benchmark of 10% and the Accord's 5% UK private asset target. Currently, private markets represent approximately 15% of Nest's portfolio. The scheme already maintains approximately £2bn in direct unlisted equity investments, with £381m (18%) deployed into UK companies, demonstrating material capital already flowing into domestic private assets. Nest's structural positioning—its young member base and decades-long cash flow positive status—provides significant competitive advantage in accessing illiquidity premiums and pursuing longer-term private market strategies. The scheme's partnership strategy centers on working with a "tight group of managers in large-scale partnerships," including recent equity co-ownership of IFM Investors, positioning it as a leading institutional capital provider in European, UK, and US private markets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.